| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/12/2002 | US6346249 Cancer treatment with antigens |
| 02/12/2002 | US6346247 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
| 02/12/2002 | CA2178915C Maleimide adduct conjugates of procainamide and napa |
| 02/09/2002 | CA2354726A1 Sodium ion-driven chloride/bi-carbonate exchanger |
| 02/07/2002 | WO2002010764A2 SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY |
| 02/07/2002 | WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | WO2002010405A2 A human disintegrin protein |
| 02/07/2002 | WO2002010402A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | WO2002010394A2 Nucleic acids, by means of which plants with altered metabolite content can be produced |
| 02/07/2002 | WO2002010392A2 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010381A1 Novel protein inhibitor of apoptosis proteins |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010353A1 Lipo-viro-particle complexes, preparation method and uses |
| 02/07/2002 | WO2002010341A1 Microsporidia isolate |
| 02/07/2002 | WO2002010340A1 $i(neospora caninum) isolate |
| 02/07/2002 | WO2002010335A2 ANTIBODIES SPECIFIC FOR UNGULATE PrP |
| 02/07/2002 | WO2002010217A2 Endothelial cell expression patterns |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | WO2002010205A2 Mutations of the mdr1 p-glycoprotein that improve its ability to confer resistance to chemotherapeutic drugs |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010198A2 Polynucleotides and polypeptides |
| 02/07/2002 | WO2002010196A2 Identification of a novel glutamine transporter |
| 02/07/2002 | WO2002009754A1 Novel remedies for cancer |
| 02/07/2002 | WO2002009753A1 Composition and method for the treatment or prevention of hiv infection |
| 02/07/2002 | WO2002009751A2 COMPOSITIONS FOR INDUCING SELF-SPECIFIC ANTI-IgE ANTIBODIES AND USES THEREOF |
| 02/07/2002 | WO2002009744A2 Modified sialic acid vaccines |
| 02/07/2002 | WO2002009737A1 High affinity integrin polypeptides and uses thereof |
| 02/07/2002 | WO2002009643A2 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 02/07/2002 | WO2002009641A2 Promyostatin peptides and methods of using same |
| 02/07/2002 | WO2002009576A2 Avian pneumovirus diagnostic system |
| 02/07/2002 | WO2002009507A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs |
| 02/07/2002 | WO2001078755A3 A novel polypeptide - human ataxia-telangiectasia mutant protein 9 and a polynucleotide encoding the same |
| 02/07/2002 | WO2001068801A3 SINGLE CHAIN ANTIBODY AGAINST MUTANT p53 |
| 02/07/2002 | WO2001059127A3 Drug metabolizing enzymes |
| 02/07/2002 | WO2001055329A3 Nucleic acids, proteins, and antibodies |
| 02/07/2002 | WO2001055315A3 Nucleic acids, proteins, and antibodies |
| 02/07/2002 | WO2001055211A3 Fil-1 theta dnas and polypeptides |
| 02/07/2002 | WO2001053469A3 Phosphatases |
| 02/07/2002 | WO2001053347A3 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 02/07/2002 | WO2001043770A3 Method for enhancing immune responses in mammals |
| 02/07/2002 | WO2001034653A3 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 02/07/2002 | WO2001029255A9 Diagnostic test for cephalic pain |
| 02/07/2002 | WO2001029226A3 Apoptosis inducing proteinaceous substance |
| 02/07/2002 | WO2001018216A3 26176, a novel calpain protease and uses thereof |
| 02/07/2002 | WO2001018050A9 T2r taste receptor family |
| 02/07/2002 | WO2001002587A3 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 02/07/2002 | WO2001001150A3 Diagnostic test for thrombotic or thromboembolic disease |
| 02/07/2002 | WO2000068376A8 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/07/2002 | US20020016975 Nucletide sequences for use as tools in genetic engineering; for use in gene therapy |
| 02/07/2002 | US20020016446 Recombinant vector and use thereof for exocellular preparation of single molecula antibodies from bacillus subtilis |
| 02/07/2002 | US20020016445 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
| 02/07/2002 | US20020015987 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects |
| 02/07/2002 | US20020015983 Escherichia coli csrB gene, RNA encoded thereby, and methods of use thereof |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | US20020015973 Detection of HLA-G |
| 02/07/2002 | US20020015972 Immunoglobulin; for use as diagnostic tool in immunoassays |
| 02/07/2002 | US20020015704 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 02/07/2002 | US20020015703 Monoclonal antibodies or soluble immunoglobulin fusion proteins to block the development of chronic Graft-Versus-Host Disease |
| 02/07/2002 | US20020015702 Control the formation and/or maintenance of epithelial and/or mesenchymal tissue; nontoxic; may be used for hair removal |
| 02/07/2002 | US20020015701 Inhibiting properdin-induced stabilization of C3 convertase by exposure to an anti-properdin antibody |
| 02/07/2002 | US20020015700 Inhibiting the interaction of a cell bearing mammalian chemokine receptor 2 (CCR2) with a ligand by binding with antibodies or functional fragments |
| 02/07/2002 | US20020015699 Process for binding an antigen to a molecule having a high binding affinity to said antigen |
| 02/07/2002 | DE10035668A1 Diagnose und Therapie von HHV-8-assoziierten Erkrankungen auf der Grundlage des HHV-8-kodierten Chemokinrezeptors Diagnosis and treatment of HHV-8-associated disorders on the basis of HHV-8-encoded chemokine receptor |
| 02/07/2002 | DE10034607A1 Multispezifisches Reagenz zur selektiven Stimulierung von Zelloberflächenrezeptoren Multi-specific reagent for the selective stimulation of cell surface receptors |
| 02/07/2002 | CA2418120A1 High affinity integrin polypeptides and uses thereof |
| 02/07/2002 | CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417612A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417574A1 Modified sialic acid vaccines |
| 02/07/2002 | CA2417568A1 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | CA2417359A1 Protein phosphatases |
| 02/07/2002 | CA2417349A1 Novel proteins and nucleic acids encoding same |
| 02/07/2002 | CA2417278A1 Identification of a novel glutamine transporter |
| 02/07/2002 | CA2417271A1 Novel protein inhibitor of apoptosis proteins |
| 02/07/2002 | CA2417195A1 G-protein coupled receptors |
| 02/07/2002 | CA2417087A1 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 02/07/2002 | CA2416877A1 Somatic cloning gene transfer for producing recombinant proteins, cells and organs |
| 02/07/2002 | CA2416800A1 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | CA2416732A1 Endothelial cell expression patterns |
| 02/07/2002 | CA2416260A1 Promyostatin peptides and methods of using same |
| 02/07/2002 | CA2416137A1 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 02/07/2002 | CA2416029A1 Antibodies specific for ungulate prp |
| 02/07/2002 | CA2415647A1 Neospora caninum isolate |
| 02/07/2002 | CA2415436A1 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | CA2415433A1 A human disintegrin protein |
| 02/06/2002 | EP1178116A1 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 02/06/2002 | EP1178115A2 Phosphodiesterase |
| 02/06/2002 | EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases |
| 02/06/2002 | EP1177440A1 Secreted proteins and polynucleotides encoding them |
| 02/06/2002 | EP1177312A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 02/06/2002 | EP1177301A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 02/06/2002 | EP1177298A1 Autotaxin variants and uses to treat diseases of metabolism |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177295A1 Ox2 receptor homologs |
| 02/06/2002 | EP1177294A1 Novel cellular regulation factor tto 20 |
| 02/06/2002 | EP1177293A1 Growth factor homolog zvegf4 |